Cargando…

Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study

Purpose: To evaluate and compare the efficacy and safety of interferon alpha-2a (IFN-α2a) and cyclosporine-A (CsA) in patients with refractory Behçet’s uveitis (BU). Methods: In this 12-month randomized, controlled, prospective trial, 26 participants (44 eyes) completed the study. Patients were rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yujing, Qu, Yi, Gao, Fei, Pei, Minghang, Liang, Anyi, Xiao, Junyan, Zhao, Chan, Zhang, Meifen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326402/ https://www.ncbi.nlm.nih.gov/pubmed/34349656 http://dx.doi.org/10.3389/fphar.2021.699903

Ejemplares similares

Genetic Association of Interleukin 33/ST2 Polymorphisms With Behcet’s Uveitis
por: Pei, Minghang, et al.
Publicado: (2021)

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
por: Lee, Ji Hwan, et al.
Publicado: (2018)

Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019)

Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease
por: Park, Ji-Youn, et al.
Publicado: (2015)

Profiling tear proteomes of patients with unilateral relapsed Behcet’s disease-associated uveitis using data-independent acquisition proteomics
por: Liang, Anyi, et al.
Publicado: (2020)

Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitis
por: Yalçindağ, Fatime Nilüfer, et al.
Publicado: (2013)

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
por: Hu, Yunwei, et al.
Publicado: (2020)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet’s disease: A systematic review of controlled trials
por: Zhou, Xinwei, et al.
Publicado: (2022)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease
por: Liang, Anyi, et al.
Publicado: (2021)

Optimizing glucocorticoid therapy for Behçet's uveitis: efficacy, adverse effects, and advances in combination approaches
por: Li, Biao, et al.
Publicado: (2023)

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

Interferon-α2a treatment for refractory Behçet's disease
por: Lai, Yung Jen, et al.
Publicado: (2018)

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
por: Xiong, Anji, et al.
Publicado: (2021)

4. A challenging case of refractory BehÇet's disease in an adolescent with sight threatening uveitis
por: Cooper, Gisella, et al.
Publicado: (2018)

Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
por: Katsuyama, Atsuko, et al.
Publicado: (2019)

Macular involvement in patients with Behçet’s uveitis
por: Kahloun, Rim, et al.
Publicado: (2012)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease
por: Alfawaz, Abullah, et al.
Publicado: (2014)

Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
por: Guney, Esra, et al.
Publicado: (2012)

Clinical Outcomes of Cyclosporine Treatment for Noninfectious Uveitis
por: Lee, Sun Ho, et al.
Publicado: (2012)

Production of interleukin-17 in Behcet’s disease is inhibited by cyclosporin A
por: Chi, Wei, et al.
Publicado: (2010)

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease
por: Sugita, Sunao, et al.
Publicado: (2012)

Glucocorticoid sensitivity in Behçet's disease
por: Quax, R A M, et al.
Publicado: (2012)

Gender Differences in Behçet's Disease Associated Uveitis
por: Ucar-Comlekoglu, Didar, et al.
Publicado: (2014)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
por: Çakar Özdal, Pınar
Publicado: (2020)

Behçet uveitis: Current practice and future perspectives
por: Aboul Naga, Shereen H., et al.
Publicado: (2022)

How challenging can it be to treat Behçet uveitis?
por: Oray, Merih, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

Efficacy and safety of adalimumab for inflammatory flare prevention in paediatric non-infectious anterior uveitis with peripheral retinal vascular leakage: a study protocol for a single-centre, randomised controlled trial
por: Song, Hang, et al.
Publicado: (2022)

Efficacy of oral glucocorticoid and cyclosporine in a case of rituximab-refractory type B insulin resistance syndrome
por: Takei, Masahiro, et al.
Publicado: (2015)

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series
por: Sun, Luxi, et al.
Publicado: (2022)

Interaction of cyclosporine with phenobarbital in cats: a preliminary study
por: HOSHINO, Yuki, et al.
Publicado: (2019)

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
por: Huang, Yin-Qiu, et al.
Publicado: (2020)

Aortitis and uveitis. A challenging case of Takayasu or Behcet disease?
por: Di Landro, Giancarla, et al.
Publicado: (2014)

A novel mechanism of macular holes in patients with Behçet's uveitis
por: Alsarhani, Waleed K., et al.
Publicado: (2022)

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
por: Fabiani, Claudia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3tsdmq7kpn9618um8dluclr593